🎉 Eppendorf Award for Young European Investigators 2024 goes to Dr. Clemens Plaschka! 🎉 The independent jury, chaired by Prof. Laura Machesky from University of Cambridge, UK, selected Dr. Clemens Plaschka from the IMP – Institute of Molecular Pathology in Vienna, Austria, as this year's winner. Dr. Plaschka receives the 20,000 euro prize for his groundbreaking research on the molecular machines that generate and export messenger RNA. Finalists also included Dr. Irma Querques from Max Perutz Laboratories, University of Vienna, Austria, for her innovative work on transposon-mediated genetic manipulation and CRISPR-associated transposition, and Dr. Phong Nguyen from Hubrecht Institute, Utrecht, Netherlands, for his pioneering research on heart regeneration mechanisms. The award ceremony took place on June 27, 2024, at the Advanced Training Center of the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany. Warm congratulations to Dr. Clemens Plaschka on this well-deserved award! 🥳 Read more here: https://lnkd.in/erXScx_E
Eppendorf ’s Post
More Relevant Posts
-
Congratulations to Ezgi İrem Bektaş who won the SPARK (SNSF Swiss National Science Foundation) grant. The 1-year grant will focus on “Decoding Cell-Instructive Properties of Biomaterials Through Sequential Exposure to Innate Immune Cells for Modulating Mesenchymal Stromal Cell Differentiation”. This study aims to determine the effects of material topographical cues for modifying and regulating the immune response by mimicking the native order of cell appearance at the material implantation site in vitro. The ultimate goal is to develop an in vitro approach to test the series of immunological events elicited by materials that have potential to be used as scaffolds for tissue regeneration.
-
-
Quantum Computing Meets Biology: A Convergence for Breakthroughs Jeya Chelliah B.Vsc Ph.D. In the rapidly evolving landscape of scientific research, the fusion of quantum computing with cell biology, immunology, and synthetic biology represents a frontier poised to revolutionize our approach to combating cancer and infectious diseases. This integration promises to unlock insights and innovations that have, until now, remained beyond our grasp. To understand the transformative potential of this synergy, let’s first dive into the essence of quantum computing through an accessible analogy. https://lnkd.in/e5Aihtyi
-
Faculty | AIAS Associate Fellow | Stem Cell Biologist | Board Member | DANWISE Director | Women in Science Advocate | Global Health Advocate | Keynote
Are you interested in learning how novel single-cell technologies advance our mechanistic understanding of muscle stem cell function in skeletal muscle regeneration? I’ll be speaking on June 17 at the Multiplex Single-Cell Proteomic Technologies Symposium in San Francisco. Join me and my colleagues in a celebration of the publication of our new book, "Revealing Uncharted Biology with Single Cell Multiplex Proteomic Technologies: Applications!" https://lnkd.in/dSkMUYkG
-
Are you a prospective PhD student interested in big data? If so, check out the newest group of Sanford Burnham Prebys faculty hires who are recruiting new students to begin in Fall 2024! #biomedicalresearch #phdstudents #bigdata
Sanford Burnham Prebys recruits a cadre of early-career scientists in the fields of cancer, neurodegeneration and aging, cardiovascular disease and computational biology. They are the best of the best, coming from some of the finest institutions and labs in the world, with skillsets and tools that once were unimagined. Learn more: https://bit.ly/45iTPfu
-
-
The last original article related to my doctoral dissertation has been recently published! This success was only possible with the entire team's hard work. Thank You, Damian Kołat (MSc. BSc. MedBiotech) and Elżbieta Płuciennik for the 4 years of cooperation on my PhD project, and I am optimistically awaiting further joint ventures 🤗 I would also like to thank the Head of the Department of Molecular Carcinogenesis, Professor Andrzej K. Bednarek, for the opportunity to implement the project in this unit 🤩 #frontiers #frontiersinneuroscience https://lnkd.in/diRw_YDU
Molecular landscapes of glioblastoma cell lines revealed a group of patients that do not benefit from WWOX tumor suppressor expression
frontiersin.org
-
How do you address reproducibility issues in science? Our Scientific Standards Hub is striving to find the answer, but a good start is bringing a bunch of brain power together–which we just did with a 2-day #ProteinScience conference. The event, "α-Twists and β-Turns of Recombinant Protein Production," spanned lectures on protein and antibody workflows, protein production case studies, structural biology, and technology development. Read more about it: https://bit.ly/4aDCMaI
Laboratory Director, Frederick National Laboratory for Cancer Research President, Leidos Biomedical Research
The Frederick National Laboratory for Cancer Research (FNL) just held a timely two-day conference at the Advanced Technology Research Facility titled: “α-Twists and β-Turns of Protein Standards.” This symposium sought to address the challenge of irreproducible results in science. The conference’s focus was on protein biology standards. It proved a popular conference with 176 registrants. Topics included protein and serology standards and it was the brainchild of the “Scientific Standards Hub” led by Dr. Leonard Freedman, our Chief Science Officer. This conference was spearheaded by FNL’s prominent proteomics expert, Dr. Dominic Esposito, who is the Director of the Protein Expression Laboratory. I am pictured standing next to Dr. Esposito (who is to my left) and to his left is Dr. Freedman.
-
-
Customer Success Story Featured on the front cover of Nature Structural & Molecular Biology, the translatome of translational control of brain development has been established, where Arraystar's tRNA qPCR array was used to profile tRNA isodecoders across five stages of mouse neocortex neurogenesis [1]. tRNA abundance was analyzed for ribosome occupancy, usage availability, and codon optimality. At codon resolution, a critical period of translational control during brain development is discovered. tRNA is a strong determinant of ribosome occupancy. Learn more about our tRNA PCR arrays here: https://lnkd.in/eEzER8qD Check out our review that discusses the tRNA repertoire and its functional significance: https://lnkd.in/g3zy4gTJ Reference [1] Harnett D. et al (2022) A critical period of translational control during brain development at codon resolution. Nat Struct Mol Biol 29(12):1277-1290 [PMID:36482253]
-
-
Below for those interested is the Abstract of my latest paper now on my website. A comparison is made of the incidence of various cancers in the '50 Hz' and '60Hz' worlds. ASR incidence rates versus GMF are fitted to appropriate polynomial distributions and analysed in parts of the world which have either 50Hz or 60 Hz electricity supplies. Gross differences are found to exist between these two ‘frequency’ worlds, suggesting that electromagnetic fields from power systems can influence development and distribution of cancers which is then discussed in terms of the latest ideas of the disease as a channelopathy. Although several competing hypotheses exist concerning how ion channel transits are influenced by fields, including Ion Cyclotron resonance, Ion Parametric resonance and the biological equivalent of the Hall effect these tend to reduce to a common dependence per ion on AC excitation frequency and background DC earth magnetic field (GMF) or Hz/ μT. Thus the ICR model, mathematically at least serves to adequately explain the results. At minima in the above distributions specific ions and their channels are involved which either corroborate with or even in some cases further inform existing cancer biology. Moreover, exciting new and simple drug free treatment possibilities are opened up.
-
Projectmanager Health at ROM regio Utrecht | Biotech entrepreneur | Marketing executive | Dedicated to make a difference in life sciences & health | Untapped fan
Tune in on the developments concerning replacing animal models to accomplish less animal suffering and better predictions in clinical situations. #ICAT #3Rcentreutrecht #hansclevers #romutrechtregion
Exciting news on our conference "3Rs and NAMs: all-inclusive?", organised together with the Transition to Animal-free Innovations programme (Transitie Proefdiervrije Innovatie). Professor Hans Clevers will share his ideas on the transition to animal-free biomedical research as Keynote speaker. As stem cell researcher and organoid pioneer, he will most certainly bring a broad perspective on the current field and valuable insights regarding the future. Make sure to secure your spot for the conference “3Rs and NAMs: all-inclusive?” using this registration form: https://lnkd.in/e7Nmbh5i. Online participation is also an option! Link to the news article: https://lnkd.in/eerbJ5Pj The conference is organised in collaboration with the Netherlands National Committee for the protection of animals used for scientific purposes (NCad).
Prof. Clevers confirmed as a Keynote speaker at the conference "3Rs and NAMs: all-inclusive?”
uu.nl
It’s possible if you like it!
3wCongratulations!